Chemoinformaics analysis of 3,5,5-Trimethylhexanal
| Molecular Weight | 142.242 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.098 | nRig | 8 |
| Exact Molecular Weight | 142.136 | nRing | 0 |
| Solubility: LogS | -2.632 | nHRing | 0 |
| Solubility: LogP | 1.169 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 27.8343 |
| nHD | 0 | BPOL | 18.9257 |
| QED | 0.571 |
| Synth | 1.946 |
| Natural Product Likeliness | 0.223 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.025 |
| CACO-2 | -4.516 |
| MDCK | 0.0000112 |
| BBB | 0.991 |
| PPB | 0.742835 |
| VDSS | 1.234 |
| FU | 0.260591 |
| CYP1A2-inh | 0.854 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.08 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.276 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.208 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.192 |
| CL | 3.978 |
| T12 | 0.654 |
| hERG | 0.082 |
| Ames | 0.072 |
| ROA | 0.009 |
| SkinSen | 0.308 |
| Carcinogencity | 0.019 |
| EI | 0.996 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.945942 |